Celgene Corp (NASDAQ:CELG)
CAPS Rating:
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
RSS Headlines
Fool UK
Recs
Great Margins and Revenue growth - price performance this year doesn't seem to reflect. Identified in my YCharts/FinViz double screen.